Shin et al. reported that TRAIL had little effect on HCC cells, while a combination of cisplatin and TRAIL significantly altered the sensitivity of HCC cells to TRAIL-induced apoptosis via the activation of the mitochondrial pathway and the amplification of the TRAIL-mediated death receptor pathway [30]. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.